The Current Standard of Care is Ineffective
from Asthma and COPD in the U.S.
1 in 8 people are affected
60% of this population
has symptoms that are uncontrolled
on ER visits and hospitalizations
from Asthma and COPD
Following the treatment plan requires daily self assessment of symptoms, and the patient has to choose the right medication and dosage accordingly.
The subjective assessment lacks compliance and often is error-prone, resulting in uncontrolled symptoms with frequent exacerbations.
No clear visibility on the patient's symptoms and patient's condition outside the standard clinical setting.
This makes it challenging to understand the level of control, effectiveness of the treatment plan, and any proactive interventions in the case of exacerbations.
First-of-its-kind Respiratory Health Platform
Patented Technology for Intelligent Health Monitoring
Transformative AI technology for passive continuous monitoring
With NO patient effort or behavior change required
Secure Web Platform for Clinicians
Daily updated risk-stratification along with actionable insights
Unprecedented visibility into the respiratory health of each patient
Patient Mobile Application
Guidance on following the treatment plan
Active monitoring and patient engagement
Curie's Solution Allows You to
Enable Personalized Care
Insights on patient's specific baselines based on longitudinal data
Insights on treatment effectiveness with data evidence
The Result: Help tailor the treatment plan
PARTNER WITH US
Adding More Value to Those Working in Value-Based Care
Curie provides a truly AI powered solution that will notify you when a patient needs your attention, making proactive interventions and significant cost savings a snap. Since no action is required from the patient, compliance is nearly 100%.
Curie can help you better manage your chronic population, improve patient outcomes and minimize unnecessary readmissions and ER visits.
Curie understands the risk of capitated fee agreements. Our easy to use tools allow you and your networks to understand who is at risk and how to intervene. This allows significant reduction in the total cost of care, including expensive ER visits and hospitalizations.
Co-Founder, Head of AI
Co-Founder, Head of Engineering
Clinical Operations Lead
Business Development Lead
Applied Machine Learning Scientist